ABSTRACT
INTRODUCTION
Pseudomonas aeruginosa is a Gram negative opportunistic human pathogen, which causes various acute and chronic nosocomial infections such as pneumonia, urinary tract and wound infections in immunocompromised hosts, particularly in burn hospitalized patients (1) .
These infections are responsible for significant human mortality, morbidity, prolonged hospital stays and increased health care costs (2, 3) . This organism possesses different factors that promote adherence to host cells and mucosal tissues, damage host tissue, elicit inflammation and disrupt defense mechanisms. This conditions aggravate in burn patients due to impairment of the skin barrier in burn patients and frequent scrubbing, debridement and manipulation of the burn site (1) . Resistance of P. aeruginosa to a wide spectrum of antibiotics has become a major clinical concern worldwide (1, 2). The extended spectrum β-lactamases (ESBLs) , may lead P. aeruginosa to be resistant to β -lactam antibiotics, including penicillins, cephalosporins and monobactams (4, 5) .
OXA and PER can be mentioned as the two of important β-lactamase enzymes, in P. aeruginosa, (3, 4) . bal PER-1 was the first group of this gene reported from France in 1991 in a single P. aeruginosa isolate from a Turkish patient (3) . P. aeruginosa strains contacting bal PER-1 are highly resistant to β-lactamase, and have strong hydrolytic activity against cephalosporins but can not hydrolyze carbapenems and cephamycins (5) . Another group of such enzymes which has high incidence in Enterobacteriaceae especially in P. aeruginosa is OXA. Owing to hydrolytic activity OXA-10 (a class D β-lactamase) is responsible for a high resistance to amino-group antibiotics, carboxypenicillins, ureido-penicillins and cephalosporins in P. aeruginosa isolates (6) .
Due to importance of the carbapenems in resistance infections management, and increasing of the imipenem resistance ESBL P. aeruginosa strains, finding the true frequency of such enzymes is mandatory. The purpose of the present study was to investigate the prevalence of these two β-lactamase genes (bla PER-1 and bla ) in imipenem resistant clinical isolates of P. aeruginosa in hospitalized patients in a main burn center of southwest of Iran.
MATERIALS AND METHODS
Bacterial Isolation. The study included 270 P. aeruginosa isolates that were recovered consecutively from clinical sites of separate patients' wounds hospitalized in Shiraz Burn Hospital (the main burn center in southwest of Iran) from May 2010 to March 2011. Collected strains were assessed with routine microbiology methods like Gram stain, pigment production on Muller-Hinton agar media, Oxidase test and non-fermentative result in TSI media. Then, PCR based assay was performed by specific primers for 16s rDNA (7) to confirm presence of P. aeruginosa. Confirmed strains were stored at -200C in Trypticase Soy Broth containing 10% glycerol.
Antimicrobial susceptibility testing. Isolated strains were tested for their resistance to imipenem using the disc diffusion method (DD), according to the Clinical and Laboratory Standards Institute (CLSI) guidelines (8) . Resistance to imipenem, were also evaluated for ESBL production using the combination disc diffusion method (CDD), recommended by the CLSI guidelines (9) . In this step, antibiotic disks (aztreonam (/30μg), ceftazidime (/30μg) cephotaxime (/30μg)) were placed around a clavulanic acid (15μg) disk on 10 cm Mueller-Hinton agar plates inoculated with 0.5 McFarland suspensions of the isolates, with 30 mm distance between each disk. After the incubation time (18 hours/37˚C) inhibition zone diameters were measured to the minimum distance. Difference of 5mm ≥ in the zone between each disk with clavulanic acid disk compare to another side of the disk showed that the strain is ESBL positive. For ESBL negative control, P. aeruginosa (ATCC 27853) was used.
Detection of bla OXA-10 and bla PER-1 PCR. ImipenemResistant P. aeruginosa strains were refreshed in Muller-Hinton broth for about 4 hours and their DNA were extracted with Accuprep® Genomic DNA Extraction Kit (Bioneer-USA) according to the manufacture protocol. To evaluate the presence of bla , bla PER-1 genes in these strains, the PCR was performed with the specific primers for these regions according to the Table-1. sources (12) . In the current study 210 (77.7%) of 270 isolated P. aeruginosa, were resistant to imipenem. It seems that most of this multidrug resistance reflects the accumulation of multiple mutations and acquirement of many resistance genes (2) . Different studies evaluated the P. aeruginosa resistant strains in different world centers specially in ICU & Burn wards so far (5, 16, 18) , which showed different pattern for the resistance of this bacteria to the different antibiotics and the frequency of the important β-lactamases (such as bla PER-1 and bla OXA-10 ) among resistant isolates. According to the results of CDD screening in our study, 168 (80.0%) isolates from 210 Imipenem resistant isolates were ESBL producing strains. Mirsalehian et al. highlighted that 39.41% of the P. aeruginosa strains isolated from hospitalized burn patients in Tehran were ESBL producers (16) .
For many years, PER β-lactamases were thought to be significant only in Turkey (PER-1) and Argentina (PER-2) (5, 18, 19) . Since 1995, PER-1 producing organisms have been disseminating in Italy (20, 21) , France (21), Spain (22) , Romania (23), Korea (24), Japan (26) , and China (27) . Bacteria with the OXA (a class D β-lactamase) have evolved to destroy β-lactam 
RESULTS
In this cross-sectional of 270 isolates of P. aeruginosa, 210 (77.7%) were resistant to the imipenem. According to the results of CDD screen, 168(80.0%) isolates were ESBL producing strains. 160 (76.2%) of them contain bla OXA-10 and 84 (40%) of resistant isolates contain bla PER-1 related genes, and 63(30.0%) of them contain both genes. 148(92.5%) of 160 bla OXA-10 containing isolates, and all of bla PER-1 containing isolates produced ESBL (Figs. 1-2) .
DISCUSSION
Burn injury is a major public health problem in many countries, and requires immediate specialized care in order to minimize mortality and morbidity (10, 11) . It is estimated that 75% of all deaths following burn injury are related to infection (12) . The infection in such patients is difficult to control due to the presence of dead burn eschar, and moist environment, that act as a good growth medium for microbes. Prolonged hospital stay and invasive diagnostic and therapeutic procedures (13, 14) .
P. aeruginosa, known as major colonizer of the burn wound, is able to accumulate different resistance and virulence factors, thrives on moist burn wound surface and survives well in the hospital environment, once it is established (14) . Burn hospitals often harbor multidrug-resistant P. aeruginosa that can serve as the source of infection (2) . Previous studies in Iran confirmed resistance to many antibiotics used routinely for treatment of burn wounds infected by P. aeruginosa. Hadadi et al. showed that P. aeruginosa isolates were resistance to ceftizoxime (99%), ceftazidime (59.6%), ticarcilin (50%), ceftriaxone (44.3%), and cefoperazone (37.5%) (15) . According to a study conducted in Shiraz Burn hospital in 2006 by Japoni A et al. almost all P. aeruginosa isolated from burn patients were resistant to all tested anti-Pseudomonal antibiotics except carbapenems (meropenem and imipenem) (16) .
Carbapenems are useful in treatment of some cases of multi-drug resistant strains of P. aeruginosa (16) . The results of our study showed a high prevalence of the imipenem resistant strains in burn patients, which is an alarming sign and should be taken into the consideration, because increasing of the antimicrobial resistant bacteria isolated from burn patients is an important issue (13) .
The accumulation of multiple mutations and acquirement of resistance genes is believed as one of the most important reasons for the multidrug resistance (2). Hence, it is very important to set up a strict and logical infection control program to detect the source of infection, bacteriological profile, antibiogram of burn wound isolates and find the responsible genes for the antimicrobial resistant in order to decrease the incidence of nosocomial infections in hospitalized burn patients and help the clinicians to better drug selection for this kind of patients.
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